Novo Nordisk enters into AI collaboration with US university
![Thomas Senderovitz, senior vice president for Data Science at Novo Nordisk | Photo: Lægemiddelstyrelsen / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14097059.ece/ALTERNATES/schema-16_9/doc7l8vrwoay81xcehaea0.jpg)
As part of its growing focus on artificial intelligence (AI), Novo Nordisk has recently decided to invest USD 10m in a five-year postdoc program at the Massachusetts Institute of Technology (MIT), reports Danish business daily Børsen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk launches its own version of ChatGPT
For subscribers
Genmab invests heavily in artificial intelligence
For subscribers
BioNTech completes acquisition and enters AI market
For subscribers